The CHICA smoking cessation system
Related Experiment Video
Updated: Jun 28, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
Stephen M Downs1, Vivienne Zhu, Vibha Anand
1Children's Health Services Research, Indiana University, Indianapolis, IN, USA.
Abstract:
Environmental tobacco smoke (ETS) exposure remains an important cause of morbidity and mortality in children. Pediatricians are well positioned to help smoking parents quit. Parents who smoke may be particularly responsive to advice to quit, repeated smoking cessation messages can be effective, and parents visit the pediatrician 8-10 times for well care in the first two years of their child's life. Yet most pediatricians do not provide smoking cessation advice. We developed a parental smoking cessation module for an established pediatric primary care decision support system (CDSS) that runs as a front-end to the Regenstrief Medical Record System. The system collects data directly from parents and guides the physician through smoking cessation counseling, using stages of change. We present the CDSS and the smoking module as well as descriptive data from our smoking cessation system. We also describe a randomized controlled trial of the system that is now underway.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease II: Emphysema
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease I: Introduction
Drug Dependence